New Automated Chemistry Analyzer Presented at IBMS 2015
|
By LabMedica International staff writers Posted on 11 Oct 2015 |
|
Caption: The new Altair 240 bench-top clinical chemistry analyzer with LIS bi-directional connectivity fulfills a need for an automated, cost-effective platform supported by the broad menu of Stanbio Chemistry liquid reagents (Photo courtesy of EKF Diagnostics).
A new clinical chemistry analyzer provides an automated bench-top platform with an integrated chemistry system supported by a broad menu of ready-to-use, bar coded reagents.
EKF Diagnostics (Cardiff, UK) announced the UK launch of its “Altair 240” clinical chemistry analyzer at the Institute of Biomedical Science Congress 2015 (IBMS, September 28-30, 2015; Birmingham, UK). Also highlighted was the latest additions to its range of Stanbio liquid-stable, LiquiColor and Liqui-UV reagents, including an assay for Procalcitonin.
Altair 240 fulfills a need for an automated, cost-effective bench-top platform supported by the reliable Stanbio Chemistry liquid reagent menu for routine and special chemistries. Altair 240 also provides the flexibility to configure open-channel applications for many esoteric assays. Built on 54 years of expertise, the system with LIS bi-directional connectivity is easy-to-use, as either a main or back-up analyzer, and is capable of performing up to 480 tests/hour (double-arm functionality yields up to 480 tests/hour).
Also presented at IBMS 2015 was the Stanbio Chemistry - Procalcitonin (PCT) LiquiColor Assay, a new rapid test enabling the quantitative determination of PCT in serum samples, EDTA, or lithium heparin plasma samples by latex-enhanced immunoturbidimetric methodology. PCT is a marker for bacterial infection and sepsis and has been recognized as an important adjunct marker in the diagnosis of sepsis. The test provides a precise result that correlates well with established methodology, within 10 minutes and requires only 20 µL of sample. The reagents may be used on almost any liquid-based chemistry analyzer with open-channel capability. Reagent kit, calibrator, and control sets are available separately.
Other products showcased at EKF’s IBMS booth included: B-Hydroxybutyrate (B-HB) LiquiColor Assay for ketosis testing; Glycated Serum Protein (GSP) LiquiColor Assay – a 2-3 week indicator of average blood glucose; Quo-Lab and Quo-Test devices for HbA1c measurement; and Hemo Control hemoglobin analyzer.
Related Links:
EKF Diagnostics
EKF Diagnostics (Cardiff, UK) announced the UK launch of its “Altair 240” clinical chemistry analyzer at the Institute of Biomedical Science Congress 2015 (IBMS, September 28-30, 2015; Birmingham, UK). Also highlighted was the latest additions to its range of Stanbio liquid-stable, LiquiColor and Liqui-UV reagents, including an assay for Procalcitonin.
Altair 240 fulfills a need for an automated, cost-effective bench-top platform supported by the reliable Stanbio Chemistry liquid reagent menu for routine and special chemistries. Altair 240 also provides the flexibility to configure open-channel applications for many esoteric assays. Built on 54 years of expertise, the system with LIS bi-directional connectivity is easy-to-use, as either a main or back-up analyzer, and is capable of performing up to 480 tests/hour (double-arm functionality yields up to 480 tests/hour).
Also presented at IBMS 2015 was the Stanbio Chemistry - Procalcitonin (PCT) LiquiColor Assay, a new rapid test enabling the quantitative determination of PCT in serum samples, EDTA, or lithium heparin plasma samples by latex-enhanced immunoturbidimetric methodology. PCT is a marker for bacterial infection and sepsis and has been recognized as an important adjunct marker in the diagnosis of sepsis. The test provides a precise result that correlates well with established methodology, within 10 minutes and requires only 20 µL of sample. The reagents may be used on almost any liquid-based chemistry analyzer with open-channel capability. Reagent kit, calibrator, and control sets are available separately.
Other products showcased at EKF’s IBMS booth included: B-Hydroxybutyrate (B-HB) LiquiColor Assay for ketosis testing; Glycated Serum Protein (GSP) LiquiColor Assay – a 2-3 week indicator of average blood glucose; Quo-Lab and Quo-Test devices for HbA1c measurement; and Hemo Control hemoglobin analyzer.
Related Links:
EKF Diagnostics
Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Plasma Control
Plasma Control Level 1
Latest Technology News
- New Diagnostic System Achieves PCR Testing Accuracy
- DNA Biosensor Enables Early Diagnosis of Cervical Cancer
- Self-Heating Microfluidic Devices Can Detect Diseases in Tiny Blood or Fluid Samples
- Breakthrough in Diagnostic Technology Could Make On-The-Spot Testing Widely Accessible
- First of Its Kind Technology Detects Glucose in Human Saliva
- Electrochemical Device Identifies People at Higher Risk for Osteoporosis Using Single Blood Drop
- Novel Noninvasive Test Detects Malaria Infection without Blood Sample
- Portable Optofluidic Sensing Devices Could Simultaneously Perform Variety of Medical Tests
- Point-of-Care Software Solution Helps Manage Disparate POCT Scenarios across Patient Testing Locations
- Electronic Biosensor Detects Biomarkers in Whole Blood Samples without Addition of Reagents
- Breakthrough Test Detects Biological Markers Related to Wider Variety of Cancers
- Rapid POC Sensing Kit to Determine Gut Health from Blood Serum and Stool Samples
- Device Converts Smartphone into Fluorescence Microscope for Just USD 50
- Wi-Fi Enabled Handheld Tube Reader Designed for Easy Portability
Channels
Molecular Diagnostics
view channel
Blood Proteins Could Warn of Cancer Seven Years before Diagnosis
Two studies have identified proteins in the blood that could potentially alert individuals to the presence of cancer more than seven years before the disease is clinically diagnosed. Researchers found... Read more (1)_1.jpg "Image: Ultrasound image of micro-histotripsy liberation of biomarkers in a tumor (Photo courtesy of Joy Wang and Pradyumna Kedarisetti)"){kind=small}
Ultrasound-Aided Blood Testing Detects Cancer Biomarkers from Cells
Ultrasound imaging serves as a noninvasive method to locate and monitor cancerous tumors effectively. However, crucial details about the cancer, such as the specific types of cells and genetic mutations... Read more_1.jpg "Image: The innovative method to customize and strengthen DNA origami structure promises breakthroughs in medicine (Photo courtesy of Shutterstock)")
.jpg "Image: The QIAstat-Dx Respiratory Panel Plus has received U.S. FDA clearance (Photo courtesy of QIAGEN)")
Hematology
view channel
Next Generation Instrument Screens for Hemoglobin Disorders in Newborns
Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more
First 4-in-1 Nucleic Acid Test for Arbovirus Screening to Reduce Risk of Transfusion-Transmitted Infections
Arboviruses represent an emerging global health threat, exacerbated by climate change and increased international travel that is facilitating their spread across new regions. Chikungunya, dengue, West... Read more
POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy
Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more
First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy
Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read moreImmunology
view channel.jpg "Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)")
AI Predicts Tumor-Killing Cells with High Accuracy
Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more
Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies
Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more
AI Tool Precisely Matches Cancer Drugs to Patients Using Information from Each Tumor Cell
Current strategies for matching cancer patients with specific treatments often depend on bulk sequencing of tumor DNA and RNA, which provides an average profile from all cells within a tumor sample.... Read more
Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment
Cancer treatment typically adheres to a standard of care—established, statistically validated regimens that are effective for the majority of patients. However, the disease’s inherent variability means... Read moreMicrobiology
view channel
Integrated Solution Ushers New Era of Automated Tuberculosis Testing
Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more
Automated Sepsis Test System Enables Rapid Diagnosis for Patients with Severe Bloodstream Infections
Sepsis affects up to 50 million people globally each year, with bacteraemia, formerly known as blood poisoning, being a major cause. In the United States alone, approximately two million individuals are... Read more
Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases
GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more
Clinical Decision Support Software a Game-Changer in Antimicrobial Resistance Battle
Antimicrobial resistance (AMR) is a serious global public health concern that claims millions of lives every year. It primarily results from the inappropriate and excessive use of antibiotics, which reduces... Read morePathology
view channel
AI Integrated With Optical Imaging Technology Enables Rapid Intraoperative Diagnosis
Rapid and accurate intraoperative diagnosis is essential for tumor surgery as it guides surgical decisions with precision. Traditional intraoperative assessments, such as frozen sections based on H&E... Read more
HPV Self-Collection Solution Improves Access to Cervical Cancer Testing
Annually, over 604,000 women across the world are diagnosed with cervical cancer, and about 342,000 die from this disease, which is preventable and primarily caused by the Human Papillomavirus (HPV).... Read more
Hyperspectral Dark-Field Microscopy Enables Rapid and Accurate Identification of Cancerous Tissues
Breast cancer remains a major cause of cancer-related mortality among women. Breast-conserving surgery (BCS), also known as lumpectomy, is the removal of the cancerous lump and a small margin of surrounding tissue.... Read more
Technology
view channel
New Diagnostic System Achieves PCR Testing Accuracy
While PCR tests are the gold standard of accuracy for virology testing, they come with limitations such as complexity, the need for skilled lab operators, and longer result times. They also require complex... Read more
DNA Biosensor Enables Early Diagnosis of Cervical Cancer
Molybdenum disulfide (MoS2), recognized for its potential to form two-dimensional nanosheets like graphene, is a material that's increasingly catching the eye of the scientific community.... Read more
Self-Heating Microfluidic Devices Can Detect Diseases in Tiny Blood or Fluid Samples
Microfluidics, which are miniature devices that control the flow of liquids and facilitate chemical reactions, play a key role in disease detection from small samples of blood or other fluids.... Read more
Breakthrough in Diagnostic Technology Could Make On-The-Spot Testing Widely Accessible
Home testing gained significant importance during the COVID-19 pandemic, yet the availability of rapid tests is limited, and most of them can only drive one liquid across the strip, leading to continued... Read moreIndustry
view channel
Danaher and Johns Hopkins University Collaborate to Improve Neurological Diagnosis
Unlike severe traumatic brain injury (TBI), mild TBI often does not show clear correlations with abnormalities detected through head computed tomography (CT) scans. Consequently, there is a pressing need... Read more
Beckman Coulter and MeMed Expand Host Immune Response Diagnostics Partnership
Beckman Coulter Diagnostics (Brea, CA, USA) and MeMed BV (Haifa, Israel) have expanded their host immune response diagnostics partnership. Beckman Coulter is now an authorized distributor of the MeMed... Read more_1.jpg "Image: Thermo Fisher will distribute Bio-Techne products across Europe (Photo courtesy of 123RF)")
